Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Takashi Kadowaki, Joakim Isendahl, Usman Khalid, Sang Yeoup Lee, Tomoyuki Nishida, Wataru Ogawa, Kazuyuki Tobe, Toshimasa Yamauchi, Soo Kyung Lim
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s2213-8587(22)00008-0
- Published
- Feb 4, 2022
- Venue
- The Lancet Diabetes & Endocrinology
- DOI
- 10.1016/s2213-8587(22)00008-0
- PubMed
- 35131037
- Categories
- Pharmacology and Obesity Treatment
- Provenance
- openalex